Preoperative chemotherapy in non-small-cell lung cancer: nothing new in n2 disease

T. De Pas, U. Pastorino, L. Spaggiari, G. Curigliano, F. de Braud, C. Robertson

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


The study was powered to investigate whether there was a difference from 45% to 60% in 2-year survival rates in patients with early-stage NSCLC treated with induction chemotherapy followed by surgery versus a control group of patients receiving primary surgery.
Original languageEnglish
Pages (from-to)2603-2604
Number of pages1
JournalJournal of Clinical Oncology
Issue number10
Publication statusPublished - 15 May 2002


  • preoperative chemotherapy
  • lung cancer
  • oncology

Cite this